|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-4-10
|
|
pubmed:abstractText |
Mycophenolate mofetil (MMF) has been successfully used to improve or prevent the development of systemic lupus erythematosus (SLE) in both humans and in several lupus-prone mice. In the present study, we evaluated mechanisms through which MMF may exert its therapeutic effect on the development of systemic autoimmunity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
878-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12686658-Animals,
pubmed-meshheading:12686658-Autoantibodies,
pubmed-meshheading:12686658-Female,
pubmed-meshheading:12686658-Glomerulonephritis,
pubmed-meshheading:12686658-Immunosuppressive Agents,
pubmed-meshheading:12686658-Lupus Erythematosus, Systemic,
pubmed-meshheading:12686658-Lupus Nephritis,
pubmed-meshheading:12686658-Mice,
pubmed-meshheading:12686658-Mice, Inbred BALB C,
pubmed-meshheading:12686658-Mice, Inbred NZB,
pubmed-meshheading:12686658-Mycophenolic Acid
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.
|
|
pubmed:affiliation |
Servicio de Nefrología, Unidad de Investigación, Hospital Universitario Marqués de Valdecilla, Av. Valdecilla s/n, E-39008 Santander, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
